+987.9%
MRNA vs VIVK
-100.0%
+1,087.9%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | VIVK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | -27.5% | +40.6% | +13.6% |
| 7D | +20.6% | -68.7% | +89.3% | +22.9% |
| 30D | +27.1% | -90.0% | +117.2% | +33.6% |
| 3M | +353.4% | -98.1% | +451.4% | +396.0% |
| 6M | +446.3% | -99.9% | +546.2% | +554.4% |
| YTD | +776.2% | -99.9% | +876.1% | +863.1% |
| 1Y | +987.9% | -100.0% | +1,087.9% | +1,222.3% |
| All | +987.9% | -100.0% | +1,087.9% | +1,222.3% |
Cumulative growth
Daily Returns
Daily percentage return beside VIVK.
Daily Out/Under-Performance
Portfolio return minus VIVK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VIVK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded VIVK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling